We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.73%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$239M
AUM Growth
+$36.3M
(+18%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
69
New
7
Increased
14
Reduced
22
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$5.85M |
| 2 |
ELGX
Endologix Inc
ELGX
|
+$5.59M |
| 3 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
+$4.62M |
| 4 |
BLUE
bluebird bio
BLUE
|
+$4.05M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$3.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$5.36M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$4.26M |
| 3 |
Bio-Techne
TECH
|
+$2.71M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$2.09M |
| 5 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.26% |
| 2 | Energy | 3.08% |
| 3 | Real Estate | 2.24% |
| 4 | Financials | 0.24% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Veracyte
VCYT
$3.7B
| $3.83M | 1.61% |
532,574
-32,358
| -6% | -$218K |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| $3.5M | 1.46% |
93,656
+9,553
| +11% | +$361K |
|
|
EVHC
28
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.46M | 1.45% |
+44,484
| New | +$3.84M |
|
29
Celldex Therapeutics
CLDX
$2.99B
| $3.27M | 1.37% |
13,890
-452
| -3% | -$98.5K |
|
30
AngioDynamics
ANGO
$611M
| $3.18M | 1.33% |
262,089
-15,234
| -5% | -$188K |
|
31
Vertex Pharmaceuticals
VRTX
$121B
| $3.06M | 1.28% |
24,320
-323
| -1% | -$39K |
|
32
Arrowhead Research
ARWR
$11.9B
| $2.85M | 1.19% |
463,140
-2,363
| -0.5% | -$13.4K |
|
|
IMMU
33
DELISTED
Immunomedics Inc
IMMU
| $2.61M | 1.09% |
+850,757
| New | +$2.37M |
|
34
HealthStream
HSTM
$819M
| $2.57M | 1.08% |
117,006
-1,346
| -1% | -$31.4K |
|
|
STRM
35
DELISTED
Streamline Health Solutions
STRM
| $2.45M | 1.03% |
115,936
+32,259
| +39% | +$875K |
|
|
ARRY
36
DELISTED
Array Biopharma Inc
ARRY
| $2.24M | 0.94% |
530,391
-458,198
| -46% | -$2.09M |
|
|
37
Bio-Techne
TECH
$11.2B
| $2.21M | 0.93% |
98,224
-118,920
| -55% | -$2.71M |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.2M | 0.92% |
395,043
+312,132
| +376% | +$2.06M |
|
|
CPHD
39
DELISTED
Cepheid Inc
CPHD
| $2.18M | 0.91% |
59,691
-4,580
| -7% | -$163K |
|
40
Karyopharm Therapeutics
KPTI
$43.5M
| $2.02M | 0.85% |
10,184
-130
| -1% | -$28.1K |
|
41
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.98M | 0.83% |
18,901
-252
| -1% | -$26.3K |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $636K | 0.27% |
2,035
| – | – |
|
43
Humana
HUM
$43.7B
| $632K | 0.26% |
3,540
| – | – |
|
44
United Therapeutics
UTHR
$25.8B
| $598K | 0.25% |
3,820
| – | – |
|
45
Elevance Health
ELV
$81.5B
| $571K | 0.24% |
4,095
| – | – |
|
46
Bristol-Myers Squibb
BMY
$133B
| $570K | 0.24% |
8,290
| – | – |
|
|
AET
47
DELISTED
Aetna Inc
AET
| $564K | 0.24% |
5,215
| – | – |
|
48
Viatris
VTRS
$20.4B
| $529K | 0.22% |
9,775
| – | – |
|
49
Becton Dickinson
BDX
$45.6B
| $523K | 0.22% |
3,480
| – | – |
|
50
Novartis
NVS
$297B
| $522K | 0.22% |
6,774
| – | – |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, First Light Asset Management held 69 positions worth $239M, up 18% from $202M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Light Asset Management deployed $21.4M of net new capital in Q4 2015, opening 7 new positions and adding to 14 existing holdings. Its largest new stake was Amedisys: 146,287 shares worth $5.75M.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 84% a quarter earlier, followed by Energy and Real Estate.
On the sell side, the largest reduction was Surgalign Holdings, Inc. Common Stock, an estimated $4.26M trimmed.
- First Light Asset Management's largest Q4 2015 buy was Amedisys: 146,287 shares worth $5.75M.
- First Light Asset Management added most to Endologix Inc in Q4 2015, an estimated $5.59M increase.
- First Light Asset Management's biggest Q4 2015 reduction was Surgalign Holdings, Inc. Common Stock, cutting an estimated $4.26M.
- First Light Asset Management fully exited Omnicell in Q4 2015, selling an estimated $5.36M.
- First Light Asset Management's ten largest holdings make up 47% of its $239M portfolio in Q4 2015.
- First Light Asset Management opened 7 new positions and closed 4 in Q4 2015.
- First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $239M.
Based on First Light Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.